Neurology

Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.

Neurology

Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M

Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.

Neurology

Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M

Subthalamic nucleus deep brain stimulation in isolated dystonia: A 3-year follow-up study.

Neurology

Ostrem JL, San Luciano M, Dodenhoff KA, Ziman N, Markun LC, Racine CA, de Hemptinne C, Volz MM, Heath SL, Starr PA

Subthalamic nucleus deep brain stimulation in isolated dystonia: A 3-year follow-up study.

Neurology

Ostrem JL, San Luciano M, Dodenhoff KA, Ziman N, Markun LC, Racine CA, de Hemptinne C, Volz MM, Heath SL, Starr PA

Progression of brain atrophy in PSP and CBS over 6 months and 1 year.

Neurology

Dutt S, Binney RJ, Heuer HW, Luong P, Attygalle S, Bhatt P, Marx GA, Elofson J, Tartaglia MC, Litvan I, McGinnis SM, Dickerson BC, Kornak J, Waltzman D, Voltarelli L, Schuff N, Rabinovici GD, Kramer JH, Jack CR, Miller BL, Rosen HJ, Boxer AL

Progression of brain atrophy in PSP and CBS over 6 months and 1 year.

Neurology

Dutt S, Binney RJ, Heuer HW, Luong P, Attygalle S, Bhatt P, Marx GA, Elofson J, Tartaglia MC, Litvan I, McGinnis SM, Dickerson BC, Kornak J, Waltzman D, Voltarelli L, Schuff N, Rabinovici GD, Kramer JH, Jack CR, Miller BL, Rosen HJ, Boxer AL

Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage.

Neurology

Bertoux M, Sarazin M, Pasquier F, Bottlaender M, de Souza LC, Mioshi E, Hornberger M, Ranasinghe KG, Rankin KP, Lobach IV, Kramer JH, Sturm VE, Bettcher BM, Possin K, You SC, Lamarre AK, Shany-Ur T, Stephens ML, Perry DC, Lee SE, Miller ZA, Gorno-Tempini ML, Rosen HJ, Boxer A, Seeley WW, Rabinovici GD, Vossel KA, Miller BL

Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage.

Neurology

Bertoux M, Sarazin M, Pasquier F, Bottlaender M, de Souza LC, Mioshi E, Hornberger M, Ranasinghe KG, Rankin KP, Lobach IV, Kramer JH, Sturm VE, Bettcher BM, Possin K, You SC, Lamarre AK, Shany-Ur T, Stephens ML, Perry DC, Lee SE, Miller ZA, Gorno-Tempini ML, Rosen HJ, Boxer A, Seeley WW, Rabinovici GD, Vossel KA, Miller BL

Polygenic risk of Alzheimer disease is associated with early- and late-life processes.

Neurology

Mormino EC, Sperling RA, Holmes AJ, Buckner RL, De Jager PL, Smoller JW, Sabuncu MR

Polygenic risk of Alzheimer disease is associated with early- and late-life processes.

Neurology

Mormino EC, Sperling RA, Holmes AJ, Buckner RL, De Jager PL, Smoller JW, Sabuncu MR

Pages